Literature DB >> 19040991

Pediatric endocrine surgery: who is operating on our children?

Charles T Tuggle1, Sanziana A Roman, Tracy S Wang, Leon Boudourakis, Daniel C Thomas, Robert Udelsman, Julie Ann Sosa.   

Abstract

BACKGROUND: High surgeon volume is associated with improved outcomes in adult endocrine surgery. This is the first population-based outcomes study for thyroidectomy/parathyroidectomy in children.
METHODS: Cross-sectional analyses were performed using 1999 to 2005 Healthcare Cost and Utilization Project Nationwide Inpatient Sample data. Outcomes included complications, length of stay (LOS), and costs. High-volume surgeons performed >30 cervical endocrine procedures per year in adults and children; pediatric surgeons restricted >90% of their practices to patients </=17 years old. Other surgeons fell into neither category. Bivariate and multivariate regression analyses were performed.
RESULTS: We included 607 patients, representing 20% of the pediatric endocrine operations done between 1999 and 2005 in the United States. Seventy-six percent of patients were female. Among the procedures performed, 92% were thyroidectomies and 8% were parathyroidectomies. Surgeons were classified as follows: 18% High-volume, 21% Pediatric, and 61% Other. High-volume surgeons had the lowest LOS (1.5 days vs 2.3 Pediatric, 2.0 Other; P = .01), costs ($12,474 vs $19,594 Pediatric, $13,614 Other; P < .01), and complications (6% vs 11% Pediatric, 10% Other; P = NS). In multivariate analyses, case volume of the endocrine surgeons was an independent predictor of LOS and costs.
CONCLUSION: High-volume surgeons have better outcomes after thyroidectomy/parathyroidectomy in children compared with Pediatric and Other surgeons. Surgeon experience was an independent predictor of LOS and costs. High-volume endocrine and pediatric surgeons could combine expertise to improve outcomes in children.

Entities:  

Mesh:

Year:  2008        PMID: 19040991     DOI: 10.1016/j.surg.2008.08.033

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  27 in total

1.  The changing pattern of diagnosing primary hyperparathyroidism in young patients.

Authors:  Irene Lou; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein
Journal:  Am J Surg       Date:  2016-06-14       Impact factor: 2.565

Review 2.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 5.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

Authors:  Steven G Waguespack; Thereasa A Rich; Nancy D Perrier; Camilo Jimenez; Gilbert J Cote
Journal:  Nat Rev Endocrinol       Date:  2011-08-23       Impact factor: 43.330

Review 6.  Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach.

Authors:  Marguerite T Parisi; Hedieh Khalatbari; Sanjay R Parikh; Adina Alazraki
Journal:  Pediatr Radiol       Date:  2019-10-16

Review 7.  [Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].

Authors:  T J Musholt; A Bockisch; T Clerici; C Dotzenrath; H Dralle; P E Goretzki; M Hermann; K Holzer; W Karges; H Krude; J Kussmann; K Lorenz; M Luster; B Niederle; C Nies; P Riss; J Schabram; P Schabram; K W Schmid; D Simon; Ch Spitzweg; Th Steinmüller; A Trupka; C Vorländer; T Weber; D K Bartsch
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

8.  Outcomes in pediatric surgery by hospital volume: a population-based comparison.

Authors:  Cabrini A LaRiviere; Jarod P McAteer; Jorge A Huaco; Michelle M Garrison; Jeffrey R Avansino; Thomas D Koepsell; Keith T Oldham; Adam B Goldin
Journal:  Pediatr Surg Int       Date:  2013-03-15       Impact factor: 1.827

9.  Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center.

Authors:  Samantha Ly; Mary C Frates; Carol B Benson; Hope E Peters; Frederick D Grant; Laura A Drubach; Stephan D Voss; Henry A Feldman; Jessica R Smith; Justine Barletta; Monica Hollowell; Edmund S Cibas; Francis D Moore; Biren Modi; Robert C Shamberger; Stephen A Huang
Journal:  J Clin Endocrinol Metab       Date:  2016-08-08       Impact factor: 5.958

10.  Pediatric Primary Hyperparathyroidism: Experience in a Tertiary Care Referral Center in a Developing Country Over Three Decades.

Authors:  Vikram Sharanappa; Anjali Mishra; Vijayalakshmi Bhatia; Sabaretnam Mayilvagnan; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2020-10-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.